David Ellis - Concepedia

Author

David Ellis

Women's and Children's Hospital

Also Known As

D ELLIS, D Ellis, D. Ellis, DAVID ELLIS, David Ellis, Ellis, David

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Women's and Children's Hospital Westmead Hospital The University of Sydney St Vincent's Hospital Sydney University of Iowa

About

David Ellis is an author at Women's and Children's Hospital specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	2.5K
2	Health Sciences	5	5	1.2K
3	Public Health	2	2	271
4	Engineering	1	1	17
5	Natural Sciences	1	1	17

David Ellis

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of <i>Candida</i> Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion Michael A. Pfaller, Daniel J. Diekema, David L. Gibbs, Journal of Clinical Microbiology Fluconazole-r IsolatesAntifungal AgentAntimicrobial SusceptibilityHealth SciencesFungal Pathogen	2010	693
Epidemiology and Host- and Variety-Dependent Characteristics of Infection Due to Cryptococcus neoformans in Australia and New Zealand Tania C. Sorrell, Graeme R. Nimmo, Bryan Speed, Clinical Infectious Diseases	2000	462
Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients Peter F. Troke, Koldo Aguirrebengoa, Carmen Arteaga, Antimicrobial Agents and Chemotherapy Antifungal AgentsSolid Organ TransplantationClinical MycologyCentral Nervous SystemDermatology	2008	288
Direct measurement of the intracellular pH of mammalian cardiac muscle. David Ellis, R C Thomas The Journal of Physiology Cardiac MuscleCardiovascular FunctionCellular PhysiologyMuscle PhysiologyHyperpolarization (Biology)	1976	243
Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients Christopher C. Blyth, Monica A. Slavin, Carolina Serena, PEDIATRICS	2009	206
Active Surveillance of Candidemia, Australia Sharon Chen, Monica A. Slavin, Quoc Nguyen, Emerging infectious diseases Diagnostic MycologyPathogenic MicrobiologyClinical MycologyHospital MedicineHealthcare-associated Infection	2006	174
Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against <i>Candida</i> and <i>Aspergillus</i> Species Frank C. Odds, Mary Motyl, Roberto Andrade, Journal of Clinical Microbiology MycologyDiagnostic MycologyAntifungal AgentSusceptibility TestingAntifungal Agents	2004	173
Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and Caspofungin Ana Espinel‐Ingroff, Beth A. Arthington‐Skaggs, Naureen Iqbal, Journal of Clinical Microbiology Fungal DiversityAntifungal AgentSusceptibility TestingAntifungal AgentsMulticenter Evaluation	2007	168
Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp. E Geoffrey Playford, Deborah Marriott, Quoc Nguyen, Critical Care Medicine	2008	156
An assessment of the efficiency of fungal DNA extraction methods for maximizing the detection of medically important fungi using PCR A. Karakousis, L.W. Tan, David Ellis, Journal of Microbiological Methods Fungal DiversityBioanalysisImportant FungiPathologyFungal Biology	2005	147

Page 1